Adage Capital Partners Gp, L.L.C. Heron Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $52.3 Billion
- Q2 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 7,600,000 shares of HRTX stock, worth $14.2 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
7,600,000
Previous 2,910,011
161.17%
Holding current value
$14.2 Million
Previous $8.06 Million
230.02%
% of portfolio
0.05%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding HRTX
# of Institutions
198Shares Held
129MCall Options Held
94.7KPut Options Held
148K-
Rubric Capital Management LP New York, NY26.7MShares$50 Million2.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.62MShares$16.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$15.6 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$13.1 Million58.47% of portfolio
-
Orbimed Advisors LLC San Diego, CA6.51MShares$12.2 Million0.55% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $222M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...